Notification

No new Notification messages

Open a Free Demat Account
Pay ZERO maintenance charges for the first year, get free stock picks daily, and more.
Track Market Movers Instantly
Stay updated with real-time data. Get insights at your fingertips.
Trade Now, Pay Later with up to 4x Leverage
Never miss a good trading opportunity due to low funds with our MTF feature.
NSE BSE
nectar lifesciences ltd. stock

NECTAR LIFESCIENCES LTD. Share Price

- - (%)
- NSE: NECLIFE

NECTAR LIFESCIENCES LTD. Share Price Update

As of the latest trading session, NECTAR LIFESCIENCES LTD. share price is currently at 51.67, which is up by 4.41 from its previous closing. Today, the stock has fluctuated between 44.25 and 53.80. Over the past year, NECTAR LIFESCIENCES LTD. has achieved a return of 69.05 %. In the last month alone, the return has been 57.86 %. Read More...

NECTAR LIFESCIENCES LTD. Performance

Day Range

Low44.25 High53.80
51.67

52 Week Range

Low 21.50 High 53.80
51.67

NECTAR LIFESCIENCES LTD. Share Price

11927

532649

NECLIFE

img img img img
No Data Available

Open Price

46.70

Prev. Close

47.25

Volume (Shares)

29114212.00

Total traded value

15043.31

Upper Circuit

56.70

Lower Circuit

37.80

Note: The current prices & values are delayed, Login to your account for live updates.

NECTAR LIFESCIENCES LTD. Fundamentals


(Standalone)

Market Cap (Cr) 1158.75
PE Ratio (TTM) 174.78
Book Value / Share 47.67
Beta 0.98
ROE 0.47%
EPS (TTM) 0.27
Dividend Yield 0.00%
Net Profit Qtr (Cr) 2.97

NECTAR LIFESCIENCES LTD. Financials

  • Key Results
  • Key Ratios
  • Balance sheet
  • Cash Flow
  • Competition

Revenue

Net income

Particulars JUN 2024 (Values in Cr)
Revenue 358.85
Operating Expense 354.94
Net Profit 2.97
Net Profit Margin (%) 0.82
Earnings Per Share (EPS) 0.13
EBITDA 40.36
Effective Tax Rate (%) 39.63
Particulars MAR 2024 (Values in Cr)
Revenue 439.85
Operating Expense 431.72
Net Profit 0.60
Net Profit Margin (%) 0.13
Earnings Per Share (EPS) 0.03
EBITDA 49.98
Effective Tax Rate (%) 94.60
Particulars DEC 2023 (Values in Cr)
Revenue 452.16
Operating Expense 450.19
Net Profit 1.57
Net Profit Margin (%) 0.34
Earnings Per Share (EPS) 0.07
EBITDA 42.67
Effective Tax Rate (%) 36.17
Particulars SEP 2023 (Values in Cr)
Revenue 397.96
Operating Expense 406.93
Net Profit 1.02
Net Profit Margin (%) 0.25
Earnings Per Share (EPS) 0.05
EBITDA 37.47
Effective Tax Rate (%) 38.41
Particulars JUN 2023 (Values in Cr)
Revenue 394.12
Operating Expense 391.53
Net Profit 1.82
Net Profit Margin (%) 0.46
Earnings Per Share (EPS) 0.08
EBITDA 36.01
Effective Tax Rate (%) 40.52
Particulars MAR 2024 (Values in Cr)
Revenue 1684.09
Operating Expense 1680.38
Net Profit 5.00
Net Profit Margin (%) 0.29
Earnings Per Share (EPS) 0.22
EBITDA 166.14
Effective Tax Rate (%) 72.59
Particulars MAR 2023 (Values in Cr)
Revenue 1523.67
Operating Expense 1607.55
Net Profit -22.46
Net Profit Margin (%) -1.47
Earnings Per Share (EPS) -1.00
EBITDA 97.91
Effective Tax Rate (%) 44.82
Particulars MAR 2022 (Values in Cr)
Revenue 1668.23
Operating Expense 1645.20
Net Profit 25.32
Net Profit Margin (%) 1.51
Earnings Per Share (EPS) 1.17
EBITDA 170.13
Effective Tax Rate (%) 26.28
Particulars MAR 2021 (Values in Cr)
Revenue 1541.82
Operating Expense 1604.95
Net Profit -73.15
Net Profit Margin (%) -4.74
Earnings Per Share (EPS) -3.26
EBITDA 87.63
Effective Tax Rate (%) 13.58
Particulars MAR 2020 (Values in Cr)
Revenue 2362.80
Operating Expense 2331.42
Net Profit 30.06
Net Profit Margin (%) 1.27
Earnings Per Share (EPS) 1.34
EBITDA 222.33
Effective Tax Rate (%) 15.89
Particulars MAR 2024 (Values in Cr)
Book Value / Share 47.68
ROE % 0.47
ROCE % 5.96
Total Debt to Total Equity 0.65
EBITDA Margin 8.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 47.47
ROE % -6.01
ROCE % -0.18
Total Debt to Total Equity 0.75
EBITDA Margin 3.19
Particulars MAR 2022 (Values in Cr)
Book Value / Share 48.51
ROE % 1.69
ROCE % 5.26
Total Debt to Total Equity 0.82
EBITDA Margin 8.33
Particulars MAR 2021 (Values in Cr)
Book Value / Share 47.36
ROE % -4.35
ROCE % 2.70
Total Debt to Total Equity 0.77
EBITDA Margin 6.40
Particulars MAR 2020 (Values in Cr)
Book Value / Share 50.66
ROE % 2.84
ROCE % 8.25
Total Debt to Total Equity 0.75
EBITDA Margin 8.48
Particulars MAR 2024 (Values in Cr)
Book Value / Share 47.68
ROE % 0.47
ROCE % 5.96
Total Debt to Total Equity 0.65
EBITDA Margin 8.63
Particulars MAR 2023 (Values in Cr)
Book Value / Share 47.47
ROE % -5.85
ROCE % -0.09
Total Debt to Total Equity 0.75
EBITDA Margin 3.29
Particulars MAR 2022 (Values in Cr)
Book Value / Share 48.46
ROE % 1.48
ROCE % 5.28
Total Debt to Total Equity 0.82
EBITDA Margin 8.35
Particulars MAR 2021 (Values in Cr)
Book Value / Share 47.30
ROE % -4.35
ROCE % 2.71
Total Debt to Total Equity 0.77
EBITDA Margin 6.41
Particulars MAR 2020 (Values in Cr)
Book Value / Share 50.59
ROE % 2.68
ROCE % 8.17
Total Debt to Total Equity 0.75
EBITDA Margin 8.42
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 19.80
Total Assets 2191.05
Total Liabilities 2191.05
Total Equity 1069.24
Share Outstanding 224260970
Price to Book Ratio 0.63
Return on Assets (%) 0.22
Return on Capital (%) 0.29
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 17.58
Total Assets 2189.21
Total Liabilities 2189.21
Total Equity 1064.59
Share Outstanding 224260970
Price to Book Ratio 0.33
Return on Assets (%) -1.10
Return on Capital (%) -1.33
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 17.80
Total Assets 2390.83
Total Liabilities 2390.83
Total Equity 1087.90
Share Outstanding 224260970
Price to Book Ratio 0.50
Return on Assets (%) 1.04
Return on Capital (%) 1.29
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 25.53
Total Assets 2388.11
Total Liabilities 2388.11
Total Equity 1062.03
Share Outstanding 224260970
Price to Book Ratio 0.39
Return on Assets (%) -3.06
Return on Capital (%) -3.73
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 21.29
Total Assets 2633.30
Total Liabilities 2633.30
Total Equity 1136.12
Share Outstanding 224260970
Price to Book Ratio 0.20
Return on Assets (%) 1.20
Return on Capital (%) 1.69
Particulars MAR 2024 (Values in Cr)
Cash & Short Term Investments 19.80
Total Assets 2191.06
Total Liabilities 2191.06
Total Equity 1069.25
Share Outstanding 224260970
Price to Book Ratio 0.63
Return on Assets (%) 0.22
Return on Capital (%) 0.29
Particulars MAR 2023 (Values in Cr)
Cash & Short Term Investments 17.57
Total Assets 2189.21
Total Liabilities 2189.21
Total Equity 1064.59
Share Outstanding 224260970
Price to Book Ratio 0.33
Return on Assets (%) -1.02
Return on Capital (%) -1.23
Particulars MAR 2022 (Values in Cr)
Cash & Short Term Investments 17.73
Total Assets 2389.70
Total Liabilities 2389.70
Total Equity 1086.86
Share Outstanding 224260970
Price to Book Ratio 0.50
Return on Assets (%) 1.05
Return on Capital (%) 1.3
Particulars MAR 2021 (Values in Cr)
Cash & Short Term Investments 25.43
Total Assets 2386.81
Total Liabilities 2386.81
Total Equity 1060.73
Share Outstanding 224260970
Price to Book Ratio 0.39
Return on Assets (%) -3.06
Return on Capital (%) -3.72
Particulars MAR 2020 (Values in Cr)
Cash & Short Term Investments 21.23
Total Assets 2632.16
Total Liabilities 2632.16
Total Equity 1134.60
Share Outstanding 224260970
Price to Book Ratio 0.20
Return on Assets (%) 1.14
Return on Capital (%) 1.6
Particulars MAR 2024 (Values in Cr)
Net Income 18.26
Cash from Operations 224.68
Cash from Investing -17.02
Cash from Financing -205.43
Net change in Cash 2.22
Free Cash Flow 254.10
Particulars MAR 2023 (Values in Cr)
Net Income -42.42
Cash from Operations 133.65
Cash from Investing 51.70
Cash from Financing -185.58
Net change in Cash -0.22
Free Cash Flow 163.71
Particulars MAR 2022 (Values in Cr)
Net Income 34.08
Cash from Operations 95.00
Cash from Investing 16.64
Cash from Financing -119.38
Net change in Cash -7.73
Free Cash Flow 119.97
Particulars MAR 2021 (Values in Cr)
Net Income -59.45
Cash from Operations 25.09
Cash from Investing -28.62
Cash from Financing 11.49
Net change in Cash 4.24
Free Cash Flow 56.33
Particulars MAR 2020 (Values in Cr)
Net Income 37.47
Cash from Operations 294.28
Cash from Investing -33.12
Cash from Financing -251.86
Net change in Cash -0.03
Free Cash Flow 349.05
Particulars MAR 2024 (Values in Cr)
Net Income 18.27
Cash from Operations 224.69
Cash from Investing -17.02
Cash from Financing -205.43
Net change in Cash 2.23
Free Cash Flow 254.10
Particulars MAR 2023 (Values in Cr)
Net Income -40.69
Cash from Operations 133.37
Cash from Investing 52.03
Cash from Financing -185.57
Net change in Cash -0.16
Free Cash Flow 163.43
Particulars MAR 2022 (Values in Cr)
Net Income 34.35
Cash from Operations 95.04
Cash from Investing 16.64
Cash from Financing -119.38
Net change in Cash -7.69
Free Cash Flow 120.01
Particulars MAR 2021 (Values in Cr)
Net Income -59.33
Cash from Operations 24.93
Cash from Investing -28.62
Cash from Financing 11.49
Net change in Cash 4.20
Free Cash Flow 56.18
Particulars MAR 2020 (Values in Cr)
Net Income 35.74
Cash from Operations 294.98
Cash from Investing -33.13
Cash from Financing -251.86
Net change in Cash 0.65
Free Cash Flow 349.74
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.79 42.72 3.67 504.17 33.57 / 77.70
BLISS GVS PHARMA LTD 131.30 13.48 1.42 1378.20 77.65 / 148.95
CIPLA LTD 1628.10 29.58 4.92 131478.83 1132.00 / 1681.05
FERMENTA BIOTECH LIMITED 299.95 0.00 3.05 882.78 144.45 / 332.50
Company Name Price P/E P/B Market Cap 52 Week Low/High
AMBALAL SARABHAI ENTERPRISES L 65.79 99.68 12.51 504.17 33.57 / 77.70
AMRUTAJAN HEALTH LTD 816.95 55.46 8.18 2361.85 556.05 / 861.40
ASTRAZENECA PHARMA IND LT 6896.90 131.62 24.21 17242.25 4050.15 / 7550.00
BLISS GVS PHARMA LTD 131.30 14.12 1.39 1378.20 77.65 / 148.95

Technicals

  • EMA & SMA
  • Resistance and Support
  • Price Change Analysis
- redarrow -
red-green-graph indicator
Bullish Moving Averages -
Bearish Moving Averages -
  • 5 Days 41.90
  • 26 Days 36.50
  • 10 Days 40.50
  • 50 Days 34.40
  • 12 Days 39.50
  • 100 Days 33.70
  • 20 Days 37.30
  • 200 Days 26.70
45.18
PIVOT
First Resistance 50.02
Second Resistance 52.80
Third Resistance 57.64
First Support 42.40
Second Support 37.56
Third Support 34.78
RSI 85.12
MACD 3.07
Commodity Channel Index (CCI) 151.44
ADX 62.73
Williams % R -3.76

Over 1 Month

down

57.86

Over 3 Months

down

59.35

Over 6 Months

down

34.61

Over 1 Year

down

69.05

Over 3 Years

down

16.93

Over 5 Years

down

29.34

NECTAR LIFESCIENCES LTD. Future

Future: Price

25 May
0 100 200 300 400 500 600

Discount/Premium

25 May
0 1 2 3 4 5 6 7

Active Calls

25 May
0 500 1000 1500 2000 2500 3000

Active Puts

25 Jul
0 500 1000 1500 2000 2500

NECTAR LIFESCIENCES LTD. Shareholding Pattern

  • Shareholding Summary
  • Historical Promotor Holding
  • Historical MF Holding
  • Historical FII Holding

Holding

Others
27.59
Promoter Holdings
55.79
FII
16.6
DII
0.0
Promoter Shares(Pledge Percentage)
100.0
Name Category Shares Shares%
Sanjiv Goyal Shareholding of Promoter and Promoter Group 5.58456E7 31.33
Sanjiv (huf) Shareholding of Promoter and Promoter Group 4.36224E7 24.47
Isengard Direct Pe Llc Public Shareholding 2.5890965E7 14.52
Ingain Traders, Llc Public Shareholding 2387012.0 1.34
Orient Alloys Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Nectar Organics Private Limited Shareholding of Promoter and Promoter Group 0.0 0.0
Raman Goyal Shareholding of Promoter and Promoter Group 0.0 0.0

NECTAR LIFESCIENCES LTD.

  • Dividend
  • Bonus
  • Split
Ex-Date Dividend Amt. Dividend Type Record Date Instrument Type
2020-09-11 0.05 Final 2020-09-15 Equity shares 2019-09-19 0.05 Final 2019-09-22 Equity shares 2018-09-19 0.05 Final 2018-09-22 Equity shares 2017-09-20 0.05 Final 2017-09-22 Equity shares 2016-09-22 0.1 Final 2016-09-24 Equity shares 2015-09-22 0.1 Final 2015-09-24 Equity shares 2014-08-21 0.1 Final 2014-08-23 Equity shares 2013-09-19 0.1 Final 2013-09-21 Equity shares 2012-09-20 0.1 Final 2012-09-22 Equity shares 2011-09-21 0.1 Final 2011-09-23 Equity shares 2010-01-21 0.25 Interim 2010-01-22 Equity shares 2009-09-03 0.1 Final 2009-09-07 Equity shares 2008-09-18 4.0 Final 2008-09-20 Equity shares 2007-09-18 2.0 Final 2007-09-20 Equity shares 2006-02-01 0.0 Interim 0001-01-01 Equity shares
Ex-Date Ex-Bonus Ratio
Ex-Date Old FV NEW FV Record Date
2008-11-12 10.0 1.0 2008-11-20

Learn More About Stocks

About NECTAR LIFESCIENCES LTD.

Read More
  • Management structure
  • Board of directors
  • Committees of the board of directors

Companies Owned by NECTAR LIFESCIENCES LTD.

We have something for everyone

Explore More Investment Options

Stocks

Secure and enhance your financial future today

investment-card-icon

IPOs

Your gateway to future financial opportunities

investment-card-icon

MTF

Explore Buy Now Pay Later and boost your capital by up to 4x  

investment-card-icon

US Stocks

Discover opportunities to invest in elite FAANG stocks

investment-card-icon

Frequently Asked Questions

What is the Share Price of Nectar Lifescience Ltd?

Answer Field

The share price of Nectar Lifescience Ltd for NSE is ₹ 51.67 and for BSE is ₹ 51.51.

What is the Market Cap of Nectar Lifescience Ltd?

Answer Field

The market cap of Nectar Lifescience Ltd for NSE is ₹ 11,58.75 Cr. and for BSE is ₹ 11,55.16 Cr. as of now.

What is the 52 Week High and Low of Nectar Lifescience Ltd?

Answer Field

The 52 Week High and Low of Nectar Lifescience Ltd for NSE is ₹ 53.80 and ₹ 21.50 and for BSE is ₹ 53.80 and ₹ 21.25.

How to Buy Nectar Lifescience Ltd share?

Answer Field

You can trade in Nectar Lifescience Ltd shares with Bajaj Broking by opening a Demat Account.

What is 1 year return for Nectar Lifescience Ltd?

Answer Field

The 1 year returns on the stock has been 69.05%.

No results found

Our Secure Trading Platforms

Level up your stock market experience: Download the Bajaj Broking App for effortless investing and trading

Bajaj Broking App Download

7.5 Lacs + Users

icon-with-text

4.8+ App Rating

icon-with-text

4 Languages

icon-with-text

₹4800 Cr MTF Book

icon-with-text
loader